South Dakota HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Status: Signed by the Governor on 2026-03-10 H.J. 547 (as of 2026-03-10)

State: South Dakota · Session: 2026 · Bill: HB 1099

Subjects: Controlled Substances, Public Health and Safety

Sponsors: Davis, Emery, Goodwin, Heermann, Moore, Muckey, Mulder, Perry, Pischke, Rehfeldt, Uhre-Balk, Wipf, Wittman

View South Dakota HB 1099 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.